“ADHD, Lead Exposure and Prevention: How Much Lead or How Much Evidence Is Needed?” Expert Review of Neurotherapeutics, 2014, www.tandfonline.com/doi/full/10.1586/14737175.8.4.519. Accessed 7 Feb. 2022.
Key targets that appear to be relevant to ADHD risk include persistent organic pollutants (such as polychlorinated biphenyls and dioxins) and lead [8]. These agents appear to attack the same neural systems already known to be involved in ADHD, and may interact with the genes already suspected in ADHD, in addition to other genes not yet identified.

“ADHD Statistics: New ADD Facts and Research.” ADDitude, 6 Oct. 2006, www.additudemag.com/statistics-of-adhd/#:~:text=ADHD%20Prevalence%20in%20Children,Control%20and%20Prevention%20(CDC). Accessed 29 Jan. 2022.

Ahn, James, et al. “Natural Product-Derived Treatments for Attention-Deficit/Hyperactivity Disorder: Safety, Efficacy, and Therapeutic Potential of Combination Therapy.” Neural Plasticity, vol. 2016, 2016, pp. 1–18, www.ncbi.nlm.nih.gov/pmc/articles/PMC4757677/, https://doi.org/10.1155/2016/1320423. Accessed 28 Nov. 2022.

Akhondzadeh, Shahin, et al. “Zinc Sulfate as an Adjunct to Methylphenidate for the Treatment of Attention Deficit Hyperactivity Disorder in Children: A Double Blind and Randomized Trial [ISRCTN64132371].” BMC Psychiatry, vol. 4, no. 1, 8 Apr. 2004, www.ncbi.nlm.nih.gov/pmc/articles/PMC400741/, https://doi.org/10.1186/1471-244x-4-9. Accessed 28 Nov. 2022.

Anheyer, Dennis, et al. “Herbal Medicines in Children with Attention Deficit Hyperactivity Disorder (ADHD): A Systematic Review.” Complementary Therapies in Medicine, vol. 30, Feb. 2017, pp. 14–23, www.sciencedirect.com/science/article/abs/pii/S0965229916303284?via%3Dihub, https://doi.org/10.1016/j.ctim.2016.11.004. Accessed 28 Nov. 2022.

Antalis, Caryl J., et al. “Omega-3 Fatty Acid Status in Attention-Deficit/Hyperactivity Disorder.” Prostaglandins, Leukotrienes and Essential Fatty Acids, vol. 75, no. 4-5, Oct. 2006, pp. 299–308, pubmed.ncbi.nlm.nih.gov/16962757/, https://doi.org/10.1016/j.plefa.2006.07.004. Accessed 30 Jan. 2022.

Arnold, L. Eugene, et al. “Zinc for Attention-Deficit/Hyperactivity Disorder: Placebo-Controlled Double-Blind Pilot Trial Alone and Combined with Amphetamine.” Journal of Child and Adolescent Psychopharmacology, vol. 21, no. 1, Feb. 2011, pp. 1–19, www.ncbi.nlm.nih.gov/pmc/articles/PMC3037197/, https://doi.org/10.1089/cap.2010.0073. Accessed 30 Jan. 2022.

“Attention-Deficit/Hyperactivity Disorder.” National Institute of Mental Health (NIMH), 2021, www.nimh.nih.gov/health/topics/attention-deficit-hyperactivity-disorder-adhd. Accessed 28 Jan. 2022.

“Attention-Deficit/Hyperactivity Disorder (ADHD).” National Institute of Mental Health (NIMH), 2014, www.nimh.nih.gov/health/statistics/attention-deficit-hyperactivity-disorder-adhd. Accessed 20 Jan. 2022.

Avcil, Sibelnur. “Association between Altered Lipid Profiles and Attention Deficit Hyperactivity Disorder in Boys.” Nordic Journal of Psychiatry, vol. 72, no. 5, 24 Apr. 2018, pp. 361–366, pubmed.ncbi.nlm.nih.gov/29688116/, https://doi.org/10.1080/08039488.2018.1465591. Accessed 30 Jan. 2022.

Baziar, Sara, et al. “Crocus Sativus L. Versus Methylphenidate in Treatment of Children with Attention-Deficit/Hyperactivity Disorder: A Randomized, Double-Blind Pilot Study.” Journal of Child and Adolescent Psychopharmacology, vol. 29, no. 3, Apr. 2019, pp. 205–212, pubmed.ncbi.nlm.nih.gov/30741567/, https://doi.org/10.1089/cap.2018.0146. Accessed 28 Nov. 2022.

Bilici, Mustafa, et al. “Double-Blind, Placebo-Controlled Study of Zinc Sulfate in the Treatment of Attention Deficit Hyperactivity Disorder.” Progress in Neuro-Psychopharmacology and Biological Psychiatry, vol. 28, no. 1, Jan. 2004, pp. 181–190, pubmed.ncbi.nlm.nih.gov/14687872/, https://doi.org/10.1016/j.pnpbp.2003.09.034. Accessed 28 Nov. 2022.

Bloch, Michael H., and Jilian Mulqueen. “Nutritional Supplements for the Treatment of ADHD.” Child and Adolescent Psychiatric Clinics of North America, vol. 23, no. 4, Oct. 2014, pp. 883–897, www.ncbi.nlm.nih.gov/pmc/articles/PMC4170184/, https://doi.org/10.1016/j.chc.2014.05.002. Accessed 7 Feb. 2022.

Bos, Dienke J, et al. “Reduced Symptoms of Inattention after Dietary Omega-3 Fatty Acid Supplementation in Boys with and without Attention Deficit/Hyperactivity Disorder.” Neuropsychopharmacology, vol. 40, no. 10, 19 Mar. 2015, pp. 2298–2306, www.ncbi.nlm.nih.gov/pmc/articles/PMC4538345/, https://doi.org/10.1038/npp.2015.73. Accessed 22 Jan. 2022.

Bosch, Annick, et al. “A Two Arm Randomized Controlled Trial Comparing the Short and Long Term Effects of an Elimination Diet and a Healthy Diet in Children with ADHD (TRACE Study). Rationale, Study Design and Methods.” BMC Psychiatry, vol. 20, no. 1, 27 May 2020, pubmed.ncbi.nlm.nih.gov/32460725/, https://doi.org/10.1186/s12888-020-02576-2. Accessed 9 Feb. 2022.

Calarge, Chadi, et al. “Serum Ferritin and Amphetamine Response in Youth with Attention-Deficit/Hyperactivity Disorder.” Journal of Child and Adolescent Psychopharmacology, vol. 20, no. 6, Dec. 2010, pp. 495–502, www.ncbi.nlm.nih.gov/pmc/articles/PMC3003494/, https://doi.org/10.1089/cap.2010.0053. Accessed 22 Jan. 2022.

CDC. “Data and Statistics about ADHD.” Centers for Disease Control and Prevention, 16 Nov. 2020, www.cdc.gov/ncbddd/adhd/data.html. Accessed 20 Jan. 2022.

Centers for Disease Control and Prevention, et al. CDC’s Second Nutrition Report: A Comprehensive Biochemical Assessment of the Nutrition Status of the U.S. Population Report Measures 58 Indicators of Diet and Nutrition New Report Uses NHANES Results. 2012.

Chovanová, Zuzana, et al. “Effect of Polyphenolic Extract, Pycnogenol^®, on the Level of 8-Oxoguanine in Children Suffering from Attention Deficit/Hyperactivity Disorder.” Free Radical Research, vol. 40, no. 9, Jan. 2006, pp. 1003–1010, pubmed.ncbi.nlm.nih.gov/17015282/, https://doi.org/10.1080/10715760600824902. Accessed 28 Nov. 2022.

Colter, Ashley L, et al. “Fatty Acid Status and Behavioural Symptoms of Attention Deficit Hyperactivity Disorder in Adolescents: A Case-Control Study.” Nutrition Journal, vol. 7, no. 1, 14 Feb. 2008, pubmed.ncbi.nlm.nih.gov/18275609/, https://doi.org/10.1186/1475-2891-7-8. Accessed 30 Jan. 2022.

Demirci, Kadir, et al. “The Investigation of Symptoms and Diagnoses of Adult-Attention Deficit/ Hyperactivity Disorder in Women with Iron Deficiency Anemia.” Noro Psikiyatri Arsivi, vol. 54, no. 1, 8 May 2017, pp. 72–77, www.ncbi.nlm.nih.gov/pmc/articles/PMC5439476/, https://doi.org/10.5152/npa.2016.12464. Accessed 11 Mar. 2021.

Dodig-Curković K;Dovhanj J;Curković M;Dodig-Radić J;Degmecić D. “[the Role of Zinc in the Treatment of Hyperactivity Disorder in Children].” Acta Medica Croatica : Casopis Hravatske Akademije Medicinskih Znanosti, vol. 63, no. 4, 2012, pubmed.ncbi.nlm.nih.gov/20034331/. Accessed 11 Mar. 2021.

Dunn, Geoffrey D, et al. Neuroinflammation as a Risk Factor for Attention Deficit Hyperactivity Disorder. Vol. 182, 1 July 2019, pp. 22–34, pubmed.ncbi.nlm.nih.gov/31103523/, https://doi.org/10.1016/j.pbb.2019.05.005. Accessed 24 June 2023.

---. Neuroinflammation as a Risk Factor for Attention Deficit Hyperactivity Disorder. Vol. 182, 1 July 2019, pp. 22–34, www.ncbi.nlm.nih.gov/pmc/articles/PMC6855401/, https://doi.org/10.1016/j.pbb.2019.05.005. Accessed 24 June 2023.

Dutta, Tusheema, et al. “Phytotherapy for Attention Deficit Hyperactivity Disorder (ADHD): A Systematic Review and Meta-Analysis.” Frontiers in Pharmacology, vol. 13, 3 May 2022, www.ncbi.nlm.nih.gov/pmc/articles/PMC9110892/, https://doi.org/10.3389/fphar.2022.827411. Accessed 28 Nov. 2022.

---. “Phytotherapy for Attention Deficit Hyperactivity Disorder (ADHD): A Systematic Review and Meta-Analysis.” Frontiers in Pharmacology, vol. 13, 3 May 2022, pubmed.ncbi.nlm.nih.gov/35592415/, https://doi.org/10.3389/fphar.2022.827411. Accessed 28 Nov. 2022.

---. “Phytotherapy for Attention Deficit Hyperactivity Disorder (ADHD): A Systematic Review and Meta-Analysis.” Frontiers in Pharmacology, vol. 13, 3 May 2022, pubmed.ncbi.nlm.nih.gov/35592415/, https://doi.org/10.3389/fphar.2022.827411. Accessed 28 Nov. 2022.

“Effects of Iron Supplementation Twice a Week on Attention Score and Haematologic Measures in Female High School Students | SMJ.” Smj.org.sg, 2014, www.smj.org.sg/article/effects-iron-supplementation-twice-week-attention-score-and-haematologic-measures-female. Accessed 10 Feb. 2022.

“Feed Your Child’s Focus: ADHD Foods, Dyes & Attention.” ADDitude, 23 Nov. 2007, www.additudemag.com/feed-your-childs-focus-adhd-food-nutrition/#:~:text=It%20found%20that%20both%20hyperactive,a%20general%20public%20health%20concern.&text=However%2C%20the%20FDA%20did%20admit,react%20adversely%20to%20these%20dyes. Accessed 7 Feb. 2022.

“Fruit and Vegetable Intake Is Inversely Associated with Severity of Inattention in a Pediatric Population with ADHD Symptoms: The MADDY Study.” Nutritional Neuroscience, 2022, www.tandfonline.com/doi/full/10.1080/1028415X.2022.2071805. Accessed 5 June 2022.

Glenn, Jordan M., et al. “Dietary Protein and Amino Acid Intake: Links to the Maintenance of Cognitive Health.” Nutrients, vol. 11, no. 6, 12 June 2019, p. 1315, www.ncbi.nlm.nih.gov/pmc/articles/PMC6627761/, https://doi.org/10.3390/nu11061315. Accessed 28 Oct. 2021.

Gordon, Heather A, et al. “Clinically Significant Symptom Reduction in Children with Attention-Deficit/Hyperactivity Disorder Treated with Micronutrients: An Open-Label Reversal Design Study.” Journal of Child and Adolescent Psychopharmacology, vol. 25, no. 10, Dec. 2015, pp. 783–798, www.ncbi.nlm.nih.gov/pmc/articles/PMC4702182/, https://doi.org/10.1089/cap.2015.0105. Accessed 28 Nov. 2022.

---. “Clinically Significant Symptom Reduction in Children with Attention-Deficit/Hyperactivity Disorder Treated with Micronutrients: An Open-Label Reversal Design Study.” Journal of Child and Adolescent Psychopharmacology, vol. 25, no. 10, Dec. 2015, pp. 783–798, www.ncbi.nlm.nih.gov/pmc/articles/PMC4702182/, https://doi.org/10.1089/cap.2015.0105. Accessed 28 Nov. 2022.

Gow, Rachel V., et al. “Total Red Blood Cell Concentrations of ω-3 Fatty Acids Are Associated with Emotion-Elicited Neural Activity in Adolescent Boys with Attention-Deficit Hyperactivity Disorder.” Prostaglandins, Leukotrienes and Essential Fatty Acids, vol. 80, no. 2-3, Feb. 2009, pp. 151–156, pubmed.ncbi.nlm.nih.gov/19230637/, https://doi.org/10.1016/j.plefa.2008.12.007. Accessed 30 Jan. 2022.

H. Robberecht, et al. “Magnesium, Iron, Zinc, Copper and Selenium Status in Attention-Deficit/Hyperactivity Disorder (ADHD).” Molecules, vol. 25, no. 19, 27 Sept. 2020, pp. 4440–4440, www.ncbi.nlm.nih.gov/pmc/articles/PMC7583976/, https://doi.org/10.3390/molecules25194440. Accessed 2 Sept. 2023.

Haimov-Kochman, Ronit, and Itai Berger. “Cognitive Functions of Regularly Cycling Women May Differ throughout the Month, Depending on Sex Hormone Status; a Possible Explanation to Conflicting Results of Studies of ADHD in Females.” Frontiers in Human Neuroscience, vol. 8, 1 Apr. 2014, www.ncbi.nlm.nih.gov/pmc/articles/PMC3978296/, https://doi.org/10.3389/fnhum.2014.00191. Accessed 7 Feb. 2022.

Hassane Zouhal, et al. “Effects of Exercise Training on Anabolic and Catabolic Hormones with Advanced Age: A Systematic Review.” Sports Medicine, vol. 52, no. 6, 22 Dec. 2021, pp. 1353–1368, pubmed.ncbi.nlm.nih.gov/34936049/, https://doi.org/10.1007/s40279-021-01612-9. Accessed 15 Mar. 2024.

Hirayama, S., et al. “The Effect of Phosphatidylserine Administration on Memory and Symptoms of Attention‐Deficit Hyperactivity Disorder: A Randomised, Double‐Blind, Placebo‐Controlled Clinical Trial.” Journal of Human Nutrition and Dietetics, vol. 27, no. s2, 17 Mar. 2013, pp. 284–291, pubmed.ncbi.nlm.nih.gov/23495677/, https://doi.org/10.1111/jhn.12090. Accessed 28 Nov. 2022.

Holton, Kathleen F., et al. “Evaluation of Dietary Intake in Children and College Students with and without Attention-Deficit/Hyperactivity Disorder.” Nutritional Neuroscience, vol. 22, no. 9, 23 Jan. 2018, pp. 664–677, www.ncbi.nlm.nih.gov/pmc/articles/PMC6309508/, https://doi.org/10.1080/1028415x.2018.1427661. Accessed 28 Nov. 2022.

https://www.facebook.com/verywell. “Why Many Women with ADHD Remain Undiagnosed.” Verywell Mind, 2021, www.verywellmind.com/add-symptoms-in-women-20394. Accessed 7 Feb. 2022.

Huss, Michael, et al. “Supplementation of Polyunsaturated Fatty Acids, Magnesium and Zinc in Children Seeking Medical Advice for Attention-Deficit/Hyperactivity Problems - an Observational Cohort Study.” Lipids in Health and Disease, vol. 9, no. 1, 2010, p. 105, www.ncbi.nlm.nih.gov/pmc/articles/PMC2955638/, https://doi.org/10.1186/1476-511x-9-105. Accessed 11 Mar. 2021.

Hwang, Wu Jeong, et al. “The Role of Estrogen Receptors and Their Signaling across Psychiatric Disorders.” International Journal of Molecular Sciences, vol. 22, no. 1, 31 Dec. 2020, p. 373, www.ncbi.nlm.nih.gov/pmc/articles/PMC7794990/, https://doi.org/10.3390/ijms22010373. Accessed 10 Feb. 2022.

Islam, Kamirul, et al. “A Study on Association of Iron Deficiency with Attention Deficit Hyperactivity Disorder in a Tertiary Care Center.” Indian Journal of Psychiatry, vol. 60, no. 1, 2018, p. 131, pubmed.ncbi.nlm.nih.gov/29736076/, https://doi.org/10.4103/psychiatry.indianjpsychiatry_197_17. Accessed 11 Mar. 2021.

Kamal, Madeeha, et al. “Is High Prevalence of Vitamin D Deficiency a Correlate for Attention Deficit Hyperactivity Disorder?” ADHD Attention Deficit and Hyperactivity Disorders, vol. 6, no. 2, 9 Mar. 2014, pp. 73–78, pubmed.ncbi.nlm.nih.gov/24610453/, https://doi.org/10.1007/s12402-014-0130-5. Accessed 30 Jan. 2022.

Kelly, Daniel M, and T Hugh Jones. “Testosterone: A Metabolic Hormone in Health and Disease.” Journal of Endocrinology, vol. 217, no. 3, 30 Jan. 2013, pp. R25–R45, pubmed.ncbi.nlm.nih.gov/23378050/, https://doi.org/10.1530/joe-12-0455. Accessed 30 Jan. 2022.

Khedr, Eman, et al. “Iron States and Cognitive Abilities in Young Adults: Neuropsychological and Neurophysiological Assessment.” European Archives of Psychiatry and Clinical Neuroscience, vol. 258, no. 8, 20 June 2008, pp. 489–496, pubmed.ncbi.nlm.nih.gov/18574611/, https://doi.org/10.1007/s00406-008-0822-y. Accessed 10 Feb. 2022.

Konikowska K;Regulska-Ilow B;Rózańska D. “The Influence of Components of Diet on the Symptoms of ADHD in Children.” Roczniki Panstwowego Zakladu Higieny, vol. 63, no. 2, 2012, pubmed.ncbi.nlm.nih.gov/22928358/. Accessed 27 Oct. 2021.

Konofal, Eric, and Samuele Cortese. “Lead and Neuroprotection by Iron in ADHD.” Environmental Health Perspectives, vol. 115, no. 8, Aug. 2007, www.ncbi.nlm.nih.gov/pmc/articles/PMC1940080/, https://doi.org/10.1289/ehp.10304. Accessed 10 Feb. 2022.

Kris-Etherton, Penny M, et al. “Nutrition and Behavioral Health Disorders: Depression and Anxiety.” Nutrition Reviews, vol. 79, no. 3, 24 May 2020, pp. 247–260, www.ncbi.nlm.nih.gov/pmc/articles/PMC8453603/, https://doi.org/10.1093/nutrit/nuaa025. Accessed 23 Feb. 2022.

Lepping, Peter, and Markus Huber. “Role of Zinc in the Pathogenesis of Attention-Deficit Hyperactivity Disorder.” CNS Drugs, July 2010, p. 1, pubmed.ncbi.nlm.nih.gov/20806985/, https://doi.org/10.2165/11537610-000000000-00000. Accessed 30 Jan. 2022.

Lindblad, Frank, et al. “Fasting Blood Glucose and HbA1c in Children with ADHD.” Psychiatry Research, vol. 226, no. 2-3, Apr. 2015, pp. 515–516, pubmed.ncbi.nlm.nih.gov/25747679/, https://doi.org/10.1016/j.psychres.2015.01.028. Accessed 30 Jan. 2022.

Lyon, M R, et al. “Effect of the Herbal Extract Combination Panax Quinquefolium and Ginkgo Biloba on Attention-Deficit Hyperactivity Disorder: A Pilot Study.” Journal of Psychiatry & Neuroscience : JPN, vol. 26, no. 3, 2001, pp. 221–8, www.ncbi.nlm.nih.gov/pmc/articles/PMC1408291/. Accessed 28 Nov. 2022.

Manor, I., et al. “The Effect of Phosphatidylserine Containing Omega3 Fatty-Acids on Attention-Deficit Hyperactivity Disorder Symptoms in Children: A Double-Blind Placebo-Controlled Trial, Followed by an Open-Label Extension.” European Psychiatry, vol. 27, no. 5, July 2012, pp. 335–342, pubmed.ncbi.nlm.nih.gov/21807480/, https://doi.org/10.1016/j.eurpsy.2011.05.004. Accessed 28 Nov. 2022.

May, James M., et al. “Mechanisms of Ascorbic Acid Stimulation of Norepinephrine Synthesis in Neuronal Cells.” Biochemical and Biophysical Research Communications, vol. 426, no. 1, Sept. 2012, pp. 148–152, www.ncbi.nlm.nih.gov/pmc/articles/PMC3449284/, https://doi.org/10.1016/j.bbrc.2012.08.054. Accessed 11 Mar. 2021.

Mehren, Aylin, et al. “Physical Exercise in Attention Deficit Hyperactivity Disorder – Evidence and Implications for the Treatment of Borderline Personality Disorder.” Borderline Personality Disorder and Emotion Dysregulation, vol. 7, no. 1, 6 Jan. 2020, www.ncbi.nlm.nih.gov/pmc/articles/PMC6945516/, https://doi.org/10.1186/s40479-019-0115-2. Accessed 2 May 2023.

Meritxell Rojo-Marticella, et al. Do Children with Attention-Deficit/Hyperactivity Disorder Follow a Different Dietary Pattern than that of Their Control Peers? Vol. 14, no. 6, 8 Mar. 2022, pp. 1131–1131, www.ncbi.nlm.nih.gov/pmc/articles/PMC8949924/#:~:text=This%20means%20that%20children%20and,cereals%2C%20and%20quality%20protein%20foods., https://doi.org/10.3390/nu14061131. Accessed 24 June 2023.

Mousain-Bosc M;Roche M;Polge A;Pradal-Prat D;Rapin J;Bali JP. “Improvement of Neurobehavioral Disorders in Children Supplemented with Magnesium-Vitamin B6. I. Attention Deficit Hyperactivity Disorders.” Magnesium Research, vol. 19, no. 1, 2014, pubmed.ncbi.nlm.nih.gov/16846100/. Accessed 28 Nov. 2022.

---. “Improvement of Neurobehavioral Disorders in Children Supplemented with Magnesium-Vitamin B6. I. Attention Deficit Hyperactivity Disorders.” Magnesium Research, vol. 19, no. 1, 2014, pubmed.ncbi.nlm.nih.gov/16846100/. Accessed 1 Mar. 2023.

Murray-Kolb, Laura E, and John L Beard. “Iron Treatment Normalizes Cognitive Functioning in Young Women.” The American Journal of Clinical Nutrition, vol. 85, no. 3, 1 Mar. 2007, pp. 778–787, pubmed.ncbi.nlm.nih.gov/17344500/, https://doi.org/10.1093/ajcn/85.3.778. Accessed 10 Feb. 2022.

Nigg, Joel T., and Kathleen Holton. “Restriction and Elimination Diets in ADHD Treatment.” Child and Adolescent Psychiatric Clinics of North America, vol. 23, no. 4, Oct. 2014, pp. 937–953, www.ncbi.nlm.nih.gov/pmc/articles/PMC4322780/, https://doi.org/10.1016/j.chc.2014.05.010. Accessed 1 Mar. 2023.

“Office of Dietary Supplements - Omega-3 Fatty Acids.” Nih.gov, 2015, ods.od.nih.gov/factsheets/Omega3FattyAcids-HealthProfessional/. Accessed 2 Sept. 2023.

“Office of Dietary Supplements - Vitamin D.” Nih.gov, 2015, ods.od.nih.gov/factsheets/VitaminD-HealthProfessional/. Accessed 20 Jan. 2022.

Parkman, Henry P., et al. “Dietary Intake and Nutritional Deficiencies in Patients with Diabetic or Idiopathic Gastroparesis.” Gastroenterology, vol. 141, no. 2, Aug. 2011, pp. 486-498.e7, pubmed.ncbi.nlm.nih.gov/21684286/, https://doi.org/10.1053/j.gastro.2011.04.045. Accessed 9 Feb. 2022.

Parletta, Natalie, et al. “Omega-3 and Omega-6 Polyunsaturated Fatty Acid Levels and Correlations with Symptoms in Children with Attention Deficit Hyperactivity Disorder, Autistic Spectrum Disorder and Typically Developing Controls.” PLOS ONE, vol. 11, no. 5, 27 May 2016, p. e0156432, pubmed.ncbi.nlm.nih.gov/27232999/, https://doi.org/10.1371/journal.pone.0156432. Accessed 30 Jan. 2022.

Pelsser, Lidy M, et al. A Randomised Controlled Trial into the Effects of Food on ADHD. Vol. 18, no. 1, 21 Apr. 2008, pp. 12–19, pubmed.ncbi.nlm.nih.gov/18431534/, https://doi.org/10.1007/s00787-008-0695-7. Accessed 24 June 2023.

---. A Randomised Controlled Trial into the Effects of Food on ADHD. Vol. 18, no. 1, 21 Apr. 2008, pp. 12–19, pubmed.ncbi.nlm.nih.gov/18431534/, https://doi.org/10.1007/s00787-008-0695-7. Accessed 24 June 2023.

Richardson, Alexandra J, and Basant K Puri. “A Randomized Double-Blind, Placebo-Controlled Study of the Effects of Supplementation with Highly Unsaturated Fatty Acids on ADHD-Related Symptoms in Children with Specific Learning Difficulties.” Progress in Neuro-Psychopharmacology and Biological Psychiatry, vol. 26, no. 2, Feb. 2002, pp. 233–239, pubmed.ncbi.nlm.nih.gov/11817499/, https://doi.org/10.1016/s0278-5846(01)00254-8. Accessed 28 Nov. 2022.

Robberecht, Harry, et al. “Magnesium, Iron, Zinc, Copper and Selenium Status in Attention-Deficit/Hyperactivity Disorder (ADHD).” Molecules, vol. 25, no. 19, 27 Sept. 2020, p. 4440, www.ncbi.nlm.nih.gov/pmc/articles/PMC7583976/, https://doi.org/10.3390/molecules25194440. Accessed 28 Nov. 2022.

Roberts, Bethan, et al. “Reproductive Steroids and ADHD Symptoms across the Menstrual Cycle.” Psychoneuroendocrinology, vol. 88, Feb. 2018, pp. 105–114, www.ncbi.nlm.nih.gov/pmc/articles/PMC5803442/, https://doi.org/10.1016/j.psyneuen.2017.11.015. Accessed 10 Feb. 2022.

Salvat, Habibeh, et al. “Nutrient Intake, Dietary Patterns, and Anthropometric Variables of Children with ADHD in Comparison to Healthy Controls: A Case-Control Study.” BMC Pediatrics, vol. 22, no. 1, 29 Jan. 2022, www.ncbi.nlm.nih.gov/pmc/articles/PMC8800296/, https://doi.org/10.1186/s12887-022-03123-6. Accessed 28 Nov. 2022.

Scassellati, Catia, et al. “Biomarkers and Attention-Deficit/Hyperactivity Disorder: A Systematic Review and Meta-Analyses.” Journal of the American Academy of Child & Adolescent Psychiatry, vol. 51, no. 10, Oct. 2012, pp. 1003-1019.e20, www.jaacap.org/article/S0890-8567(12)00605-3/fulltext, https://doi.org/10.1016/j.jaac.2012.08.015. Accessed 10 Feb. 2022.

Seyedi, Marzieh, et al. “The Effect of Vitamin D3 Supplementation on Serum BDNF, Dopamine, and Serotonin in Children with Attention-Deficit/Hyperactivity Disorder.” CNS & Neurological Disorders - Drug Targets, vol. 18, no. 6, 30 Aug. 2019, pp. 496–501, pubmed.ncbi.nlm.nih.gov/31269890/, https://doi.org/10.2174/1871527318666190703103709. Accessed 1 Mar. 2023.

Sharif, Mohammad Reza, et al. “The Relationship between Serum Vitamin D Level and Attention Deficit Hyperactivity Disorder.” Iranian Journal of Child Neurology, vol. 9, no. 4, 2015, pp. 48–53, www.ncbi.nlm.nih.gov/pmc/articles/PMC4670977/#:~:text=However%2C%20there%20was%20a%20statistically,vitamin%20D%20level%20below%20normal. Accessed 29 Jan. 2022.
The remaining 78.4% children had serum vitamin D level below normal.

Sinn, N., et al. “Cognitive Effects of Polyunsaturated Fatty Acids in Children with Attention Deficit Hyperactivity Disorder Symptoms: A Randomised Controlled Trial.” Prostaglandins, Leukotrienes and Essential Fatty Acids, vol. 78, no. 4-5, Apr. 2008, pp. 311–326, pubmed.ncbi.nlm.nih.gov/18514501/, https://doi.org/10.1016/j.plefa.2008.04.004. Accessed 28 Nov. 2022.

Sinn, Natalie, and Janet Bryan. “Effect of Supplementation with Polyunsaturated Fatty Acids and Micronutrients on Learning and Behavior Problems Associated with Child ADHD.” Journal of Developmental & Behavioral Pediatrics, vol. 28, no. 2, Apr. 2007, pp. 82–91, pubmed.ncbi.nlm.nih.gov/17435458/, https://doi.org/10.1097/01.dbp.0000267558.88457.a5. Accessed 28 Nov. 2022.

Skalny, Anatoly V, et al. “Serum Zinc, Copper, Zinc-To-Copper Ratio, and Other Essential Elements and Minerals in Children with Attention Deficit/Hyperactivity Disorder (ADHD).” Journal of Trace Elements in Medicine and Biology, vol. 58, 1 Mar. 2020, pp. 126445–126445, pubmed.ncbi.nlm.nih.gov/31869738/, https://doi.org/10.1016/j.jtemb.2019.126445. Accessed 2 Sept. 2023.

Stevens, Laura, et al. “EFA Supplementation in Children with Inattention, Hyperactivity, and Other Disruptive Behaviors.” Lipids, vol. 38, no. 10, Oct. 2003, pp. 1007–1021, pubmed.ncbi.nlm.nih.gov/14669965/, https://doi.org/10.1007/s11745-006-1155-0. Accessed 28 Nov. 2022.

Stevens, Laura J., et al. “Dietary Sensitivities and ADHD Symptoms: Thirty-Five Years of Research.” Clinical Pediatrics, vol. 50, no. 4, 2 Dec. 2010, pp. 279–293, pubmed.ncbi.nlm.nih.gov/21127082/, https://doi.org/10.1177/0009922810384728. Accessed 11 Mar. 2021.

Surman, Craig, et al. “Does L-Methylfolate Supplement Methylphenidate Pharmacotherapy in Attention-Deficit/Hyperactivity Disorder?” Journal of Clinical Psychopharmacology, vol. 39, no. 1, Jan. 2019, pp. 28–38, pubmed.ncbi.nlm.nih.gov/30566416/, https://doi.org/10.1097/jcp.0000000000000990. Accessed 29 Jan. 2022.

Tian, Xiaoyi, et al. “Urinary Metabolomic Study in a Healthy Children Population and Metabolic Biomarker Discovery of Attention-Deficit/Hyperactivity Disorder (ADHD).” Frontiers in Psychiatry, vol. 13, 20 May 2022, www.ncbi.nlm.nih.gov/pmc/articles/PMC9163378/, https://doi.org/10.3389/fpsyt.2022.819498. Accessed 28 Nov. 2022.

---. “Urinary Metabolomic Study in a Healthy Children Population and Metabolic Biomarker Discovery of Attention-Deficit/Hyperactivity Disorder (ADHD).” Frontiers in Psychiatry, vol. 13, 20 May 2022, www.ncbi.nlm.nih.gov/pmc/articles/PMC9163378/, https://doi.org/10.3389/fpsyt.2022.819498. Accessed 28 Nov. 2022.

Tolppanen, Anna-Maija, et al. “The Association of 25-Hydroxyvitamin D3 and D2 with Behavioural Problems in Childhood.” PLoS ONE, vol. 7, no. 7, 10 July 2012, p. e40097, www.ncbi.nlm.nih.gov/pmc/articles/PMC3393748/, https://doi.org/10.1371/journal.pone.0040097. Accessed 30 Jan. 2022.

Trebatická, Jana, et al. “Treatment of ADHD with French Maritime Pine Bark Extract, Pycnogenol®.” European Child & Adolescent Psychiatry, vol. 15, no. 6, 13 May 2006, pp. 329–335, pubmed.ncbi.nlm.nih.gov/16699814/, https://doi.org/10.1007/s00787-006-0538-3. Accessed 28 Nov. 2022.

UP;Dingankar, Dave. “An Open-Label Study to Elucidate the Effects of Standardized Bacopa Monnieri Extract in the Management of Symptoms of Attention-Deficit Hyperactivity Disorder in Children.” Advances in Mind-Body Medicine, vol. 28, no. 2, 2014, pubmed.ncbi.nlm.nih.gov/24682000/. Accessed 28 Nov. 2022.

Villagomez, Amelia, and Ujjwal Ramtekkar. “Iron, Magnesium, Vitamin D, and Zinc Deficiencies in Children Presenting with Symptoms of Attention-Deficit/Hyperactivity Disorder.” Children, vol. 1, no. 3, 29 Sept. 2014, pp. 261–279, www.ncbi.nlm.nih.gov/pmc/articles/PMC4928738/, https://doi.org/10.3390/children1030261. Accessed 22 Jan. 2022.

Wang, Liang-Jen, et al. “Dehydroepiandrosterone Sulfate, Free Testosterone, and Sex Hormone-Binding Globulin on Susceptibility to Attention-Deficit/Hyperactivity Disorder.” Psychoneuroendocrinology, vol. 103, May 2019, pp. 212–218, pubmed.ncbi.nlm.nih.gov/30711898/, https://doi.org/10.1016/j.psyneuen.2019.01.025. Accessed 10 Feb. 2022.

“Women, Hormones, and ADHD.” ADDitude, 25 Feb. 2009, www.additudemag.com/women-hormones-and-adhd/. Accessed 22 Jan. 2022.

World. “Dementia.” Who.int, World Health Organization: WHO, 15 Mar. 2023, www.who.int/news-room/fact-sheets/detail/dementia. Accessed 6 Sept. 2023.

Yi, Sang-Wook, et al. “Total Cholesterol and All-Cause Mortality by Sex and Age: A Prospective Cohort Study among 12.8 Million Adults.” Scientific Reports, vol. 9, no. 1, 7 Feb. 2019, www.ncbi.nlm.nih.gov/pmc/articles/PMC6367420/, https://doi.org/10.1038/s41598-018-38461-y. Accessed 16 Feb. 2022.

Jamanetwork.com, 2023, jamanetwork.com/journals/jamapediatrics/fullarticle/485884. Accessed 22 July 2023.